Menu People

The BIO Agency

sold to

Tech Mahindra

July 2016

 

About the Client

Ranked as leaders in their field, The BIO Agency specialises in digital transformation and innovation, helping organisations change the way they engage with their customers. Based in London with 200 employees, The BIO Agency serves brands across Financial Services, Retail, Property, Travel, and Technology sectors.
 

About the Deal

GP Bullhound, the technology investment bank, acted as the exclusive financial advisor to The BIO Agency on its sale to Tech Mahindra.This strategic acquisition will further strengthen Tech Mahindra’s focus on Digital and enable the Company to engage with its clients at the start of the journey and more importantly, help design the customer experience for their businesses. As GP Bullhound’s 15th digital agency transaction in the last 24 months, this deal underlines the firm’s international reach and depth of experience in digital marketing and digital services, following on from recent successful transactions completed for clients such as Conrad Caine, Essence, Designit, Fjord, Glispa, Seren, Realise, TLGG, Somo, Great Fridays and Fetch.
 

Quotes

Peter Veash, Co-Founder & CEO of The BIO Agency said: “We are very excited to be entering the next stage of BIO’s growth journey with a global partner like Tech Mahindra. Tech Mahindra’s deep technology expertise and global footprint will allow us to deepen our offering, and provide clients with an end-to-end digital transformation solution. GP Bullhound’s global reach and impressive knowledge of the digital transformation sector were instrumental in finding a partner that shares BIO’s conviction that digital is key to creating value at the enterprise and shareholder level.”
 
Claudio Alvarez, Director at GP Bullhound, commented: “I am delighted to have advised one of the leading digital consultancies in Europe, and this transaction further highlights GP Bullhound’s record of working with category leaders in the digital transformation sector. This partnership will accelerate BIO’s growth in a space that is experiencing phenomenal demand.”